Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

BACKGROUND Chronic heart failure is one of a number of disorders associated with the development of a wasting syndrome. The precise mechanisms of this remain unknown, but previous studies have suggested a role for immune and neurohormonal factors. METHODS We aimed to investigate in detail the differences in body composition (dual X-ray absorptiometry) and the relationship to candidate biochemical factors of the immune, neurohormonal and metabolic systems in 15 healthy controls, 36 stable non-cachectic and 18 cachectic patients with chronic heart failure. RESULTS Non-cachectic patients showed reduced leg lean tissue (-9.1%, P<0.01) compared to controls. Cachectic patients had significantly reduced lean (-21.0% vs controls, -19.9% vs non-cachectics), fat (-33.0% vs controls, -37. 0% vs non-cachectics) and bone tissue (-17.5% vs controls, -15.9% vs non-cachectics) (all P<0.0001). Cachectic patients showed a significantly increased cortisol/dehydroepiandrosterone ratio (+203% vs controls, P<0.0001; +89% vs non-cachectics, P=0.0011) and increased cytokine levels (TNF-alpha, soluble TNF-receptor 1, interleukin-6). The levels of catabolic hormones and cytokines correlated significantly with reduced muscle and fat tissue content and reduced bone mass. CONCLUSION Peripheral loss of muscle tissue is a general finding in chronic heart failure. The wasting in cardiac cachexia affects all tissue compartments and is significantly related to neurohormonal and immunological abnormalities.

[1]  S. Anker,et al.  Insulin resistance in chronic heart failure. , 2000, Journal of cardiovascular pharmacology.

[2]  S. Anker,et al.  Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. , 1997, Journal of the American College of Cardiology.

[3]  S. Yamaguchi,et al.  Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. , 1997, Japanese circulation journal.

[4]  P. Ponikowski,et al.  Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.

[5]  M. Fisher,et al.  Skeletal muscle atrophy and peak oxygen consumption in heart failure. , 1997, The American journal of cardiology.

[6]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[7]  C. Lang,et al.  Skeletal muscle mass and exercise performance in stable ambulatory patients with heart failure. , 1997, Journal of applied physiology.

[8]  C. Catani,et al.  Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. , 1996, Heart.

[9]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[10]  M. Packer Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? , 1995, Circulation.

[11]  H. Broxmeyer,et al.  Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. , 1995, The Journal of clinical investigation.

[12]  M. Fisher,et al.  Increased Resting Metabolic Rate in Patients with Congestive Heart Failure , 1994, Annals of Internal Medicine.

[13]  T. LeJemtel,et al.  Pathophysiological Correlates of Increased Serum Tumor Necrosis Factor in Patients With Congestive Heart Failure: Relation to Nitric Oxide‐Dependent Vasodilation in the Forearm Circulation , 1994, Circulation.

[14]  S. Yamaguchi,et al.  Two Types of soluble Tumor Necrosis Factor (TNF) Receptors Are Increased in Relation to Severity in Heart Failure , 1994 .

[15]  M. Piepoli,et al.  Predictors of exercise capacity in chronic heart failure. , 1994, European heart journal.

[16]  D. Mann,et al.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. , 1994, Chest.

[17]  D. Mancini,et al.  Osteoporosis and bone morbidity in cardiac transplant recipients. , 1994, The American journal of medicine.

[18]  G. Morris,et al.  Tumour necrosis factor alpha in severe congestive cardiac failure. , 1993, British heart journal.

[19]  M. Elia,et al.  Assessment of the composition of major body regions by dual-energy X-ray absorptiometry (DEXA), with special reference to limb muscle mass. , 1992, Clinical physiology.

[20]  B. Lees,et al.  Sex- and menopause-associated changes in body-fat distribution. , 1992, The American journal of clinical nutrition.

[21]  R. Lenkinski,et al.  Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure , 1992, Circulation.

[22]  M. Weiner,et al.  Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. , 1991, The Journal of clinical investigation.

[23]  J. McMurray,et al.  Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.

[24]  T. Fahey,et al.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. , 1990, The Journal of clinical investigation.

[25]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[26]  R B Mazess,et al.  Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. , 1990, The American journal of clinical nutrition.

[27]  J. Pomposelli,et al.  Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. , 1989, The Journal of clinical investigation.

[28]  L. Stevenson,et al.  Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[29]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[30]  D. Morgan,et al.  POTASSIUM DEPLETION AND TISSUE LOSS IN CHRONIC HEART-DISEASE , 1979, The Lancet.

[31]  S. Abraham,et al.  Weight by height and age for adults 18-74 years. United States, 1971-74. , 1979, Vital and health statistics. Series 11, Data from the National Health Survey.

[32]  J. G. Pittman,et al.  The Pathogenesis of Cardiac Cachexia , 1964, The New England journal of medicine.

[33]  A. Katz,et al.  DISEASE OF THE HEART IN THE WORKS OF HIPPOCRATES , 1962, British heart journal.